Epigenomics AG
09.09.2015 17:02
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Voting Rights: Release of Voting Rights Notifications (§ 21 para. 1 WpHG)
in Accordance with § 26 para. 1 WpHG (German Securities Trading Act) with
the Aim of an Europe-wide Distribution
Issuer:
Epigenomics AG
- ISIN DE000A11QW50 -
Geneststr. 5
10829 Berlin
Deutschland
Voting Rights Notifications:
1. On 7 September 2015, the company Morgan Stanley, Wilmington, Delaware,
USA, notified Epigenomics AG of voting rights in Epigenomics AG
pursuant to sec. 21 para. 1 WpHG as follows:
On 1 September 2015, as a consequence of the disposal of shares to which
voting rights are attached, the share of Morgan Stanley in the voting
rights of Epigenomics AG fell below the 3 per cent threshold of sec. 21
para. 1 WpHG and amounted, as at this date, to 0.01 per cent of the voting
rights (2,500 voting rights) in Epigenomics AG.
All 0.01 per cent of the voting rights (2,500 voting rights) are attributed
to Morgan Stanley pursuant to sec. 22 para. 1 sent. 1 no. 1 WpHG.
2. Furthermore, on 7 September 2015, Morgan Stanley Capital Management,
LLC, Wilmington, Delaware, USA, notified Epigenomics AG of voting
rights in Epigenomics AG pursuant to sec. 21 para. 1 WpHG as follows:
On 1 September 2015, as a consequence of the disposal of shares to which
voting rights are attached, the share of Morgan Stanley Capital Management,
LLC in the voting rights of Epigenomics AG fell below the 3 per cent
threshold of sec. 21 para. 1 WpHG and amounted, as at this date, to 0.01
per cent of the voting rights (2,500 voting rights) in Epigenomics AG.
All 0.01 per cent of the voting rights (2,500 voting rights) are attributed
to Morgan Stanley Capital Management, LLC pursuant to sec. 22 para. 1 sent.
1 no. 1 WpHG.
3. Furthermore, on 7 September 2015, Morgan Stanley Domestic Holdings,
Inc., Wilmington, Delaware, USA, notified Epigenomics AG of voting
rights in Epigenomics AG pursuant to sec. 21 para. 1 WpHG as follows:
On 1 September 2015, as a consequence of the disposal of shares to which
voting rights are attached, the share of Morgan Stanley Domestic Holdings,
Inc. in the voting rights of Epigenomics AG fell below the 3 per cent
threshold of sec. 21 para. 1 WpHG and amounted, as at this date, to 0.01
per cent of the voting rights (2,500 voting rights) in Epigenomics AG.
All 0.01 per cent of the voting rights (2,500 voting rights) are attributed
to Morgan Stanley Domestic Holdings, Inc. pursuant to sec. 22 para. 1 sent.
1 no. 1 WpHG.
4. Furthermore, on 7 September 2015, Morgan Stanley & Co. LLC, Wilmington,
Delaware, USA, notified Epigenomics AG of voting rights in Epigenomics
AG pursuant to sec. 21 para. 1 WpHG as follows:
On 1 September 2015, as a consequence of the disposal of shares to which
voting rights are attached, the share of Morgan Stanley & Co. LLC in the
voting rights of Epigenomics AG fell below the 3 per cent threshold of sec.
21 para. 1 WpHG and amounted, as at this date, to 0.00 per cent of the
voting rights (0 voting rights) in Epigenomics AG.
Date of release: 9 September 2015
Epigenomics AG
The Executive Board
Contact:
Epigenomics AG
Antje Zeise
Manager Investor Relations
Tel.: +49 (0)30 24345 386
Fax: +49 (0)30 24345 555
Email: antje.zeise@epigenomics.com
09.09.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Epigenomics AG
Geneststraße 5
10829 Berlin
Germany
Internet: www.epigenomics.com
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
09. September 2015 - 0:00 (CEST)